구조모아 (StructureMoa)항암 chemical structure spider web
방문타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | chromosomal translocation analysis (chromosomal translocation analysis) Novartis Pharmaceuticals·Leukemia 9 trials |
|---|---|
Overview Program | chromosomal translocation analysis |
Overview Company | Novartis Pharmaceuticals |
Overview Modality | CGT |
Overview Target | Leukemia |
Overview Indication | Brain and Central Nervous System Tumors; Lymphoma |
Overview Phase | PRECLINICAL |
Overview Status | ACTIVE |
Overview Content status | Standard Database |
Overview Data Confidence | Data Confidence · Medium |
Overview Development Signal | Development Signal · Watch |
Overview Approval status | Investigational |
Toxicology Major finding | Synergistic physiological and transcriptomic profiling deciphers an early coordinated defense network driving aluminum tolerance in sorghum (Sorghum bicolor L.).. Aluminum (Al) toxicity severely restricts sorghum growth and yield in acidic soils, particularly during seedling establishment, a stage when root systems are most vulnerable. To decode the core physiological and molecular mechanisms of A… |
Clinical Safety signal | Synergistic physiological and transcriptomic profiling deciphers an early coordinated defense network driving aluminum tolerance in sorghum (Sorghum bicolor L.).. Aluminum (Al) toxicity severely restricts sorghum growth and yield in acidic soils, particularly during seedling establishment, a stage when root systems are most vulnerable. To decode the core physiological and molecular mechanisms of A… |
Clinical Program phase | PRECLINICAL |
타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | chromosomal translocation analysis (chromosomal translocation analysis) Novartis Pharmaceuticals·Leukemia 9 trials |
|---|---|
Overview Program | chromosomal translocation analysis |
Overview Company | Novartis Pharmaceuticals |
Overview Modality | CGT |
Overview Target | Leukemia |
Overview Indication | Brain and Central Nervous System Tumors; Lymphoma |
Overview Phase | PRECLINICAL |
Overview Status | ACTIVE |
Overview Content status | Standard Database |
Overview Data Confidence | Data Confidence · Medium |
Overview Development Signal | Development Signal · Watch |
Overview Approval status | Investigational |
Toxicology Major finding | Synergistic physiological and transcriptomic profiling deciphers an early coordinated defense network driving aluminum tolerance in sorghum (Sorghum bicolor L.).. Aluminum (Al) toxicity severely restricts sorghum growth and yield in acidic soils, particularly during seedling establishment, a stage when root systems are most vulnerable. To decode the core physiological and molecular mechanisms of A… |
Clinical Safety signal | Synergistic physiological and transcriptomic profiling deciphers an early coordinated defense network driving aluminum tolerance in sorghum (Sorghum bicolor L.).. Aluminum (Al) toxicity severely restricts sorghum growth and yield in acidic soils, particularly during seedling establishment, a stage when root systems are most vulnerable. To decode the core physiological and molecular mechanisms of A… |
Clinical Program phase | PRECLINICAL |
추천 비교
추천 비교